Rapid Diagnostic Testing for HIV:
Clinical Implications of a New Diagnostic Tool
CE CREDIT IS NO LONGER AVAILABLE FOR THIS ACTIVITY
Course
#: 06HC02-DE02
Go to Article
Target Audience:
This activity is designed for physicians and nurses.
Fee for Credit: No Fee
Original Release Date: March 2005
Reviewed and Updated: May 25, 2006
Expiration Date: December
31, 2007 EXPIRED
Statement of Need:
The CDC recommended incorporation of Rapid HIV testing in both HIV prevention programs and regular primary care, as an important tool to improve earlier identification of individuals with HIV infection and to engage them in HIV medical care (HIV Prevention: New Strategies for a Changing Epidemic, April 2003). The CDC also published guidelines for use of rapid testing
to reduce vertical transmission when women
present in labor with unknown HIV status.
New Jersey Department of Health and Senior
Services (NJDHSS) data indicates that the
post-test counseling rate at publicly funded
counseling and testing sites has improved from
65% to 99% in the 10,601 tests conducted in
the first year of rapid HIV testing, beginning
in November 2003. The proportion of persons
testing HIV positive increased from 2% to
2.5% with rapid HIV testing, and 59% were
newly identified. These people are referred
for treatment, prevention services, and social
services. Clinicians who are aware of benefits,
availability, and strategies for incorporating
Rapid HIV testing in their practices will be
more likely to use it as a tool to increase early
detection and treatment of HIV infection and
AIDS.
Learning Objectives:
Upon the completion of this activity, participants should be able to:
- Recognize the clinical diagnostic role of rapid HIV testing.
- Understand the role of rapid HIV testing to reduce the risk of vertical transmission when women present in labor with unknown HIV status.
- Assess if rapid HIV testing can be integrated into their practice setting.
- Define when preliminary positive rapid test results can be used to start antiretroviral therapy.
- Discuss confirmatory HIV testing for preliminary positive rapid test results.
Method of Instruction:
Participants should read the learning objectives and review the activity in its entirety. After reviewing the material, complete the selfassessment test consisting of a series of
multiple-choice questions. Upon completing this activity as designed and
achieving a passing score of 70% or more on the
self-assessment test, participants will receive a
CME credit letter awarding AMA/PRA category 1
credit.
Estimated time to complete this activity as designed is 1 hour.
Accreditation
UMDNJ–Center for Continuing and Outreach Education is accredited
by the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.
UMDNJ–Center for Continuing and Outreach Education designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
The activity was prepared in accordance with the ACCME Essentials. This activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by Dion Richetti, DC, Patricia Kloser, MD, MPH, and Bonnie Abedini, BSN, RN.
Faculty:
Sindy Paul, MD, MPH
Sindy M. Paul, MD, MPH, is Medical Director for the New Jersey Department of Health and Senior Services, Division of HIV/AIDS Services; Director of the Preventive Medicine: Public Health Residency Program at the New Jersey Department
of Health and Senior Services; and is an assistant Clinical Professor at the University of Medicine and Dentistry of New Jersey
Evan M. Cadoff, MD
Evan Cadoff, MD, is Associate Professor of Pathology and Laboratory Medicine at University of Medicine and Dentistry of New Jersey, Chief, Division of Chemical Pathology, Robert Wood Johnson Medical School; and Medical Director, University Diagnostic Laboratories
Eugene Martin, Ph.D
Eugene Martin, PhD, is Associate Professor of Pathology and Laboratory Medicine at University of Medicine and Dentistry of New Jersey at Robert Wood Johnson Medical School and Administrative Director, University Diagnostic Laboratories (UDL) and UDL Subdirector, Point of Care Testing
Disclosure:
In accordance with the disclosure policies of UMDNJ and to conform with ACCME and FDA guidelines, all program faculty are required to disclose to the activity participants:
- the existence of any financial interest or other relationships with the manufacturers of any commercial products/devices, or providers of commercial services, that relate to the content of their presentation/material, or the commercial contributors of this activity, that could be perceived as a real or apparent conflict of interest; and
- the identifi cation of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.
Faculty Disclosure Declarations:
The faculty listed below declare that they have no financial relationships with any corporate organization whose product(s) will be discussed in this presentation:
Sindy Paul, MD, MPH
Eugene G. Martin, PhD
Evan Cadoff, MD
Patricia Kloser, MD, MPH (Field Tester)
Bonnie Abedini, BSN, RN (Field Tester)
Off-Label Usage Disclosure:
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
Disclaimer:
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of NJDHSS, Division of HIV/AIDS Services, UMDNJ, or any manufacturer of pharmaceuticals. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. This is particularly important when a drug is new or infrequently prescribed.
Copyright © 2005 UMDNJ-Center for Continuing and Outreach Education. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from UMDNJ-Center for Continuing and Outreach Education.
Grantor Acknowledgement:
This activity is supported by an educational grant from NJDHSS Division of HIV/AIDS Services through a MOA titled, “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.”
|